MAVERICK CAPITAL LTD
SuperinvestorMaverick Capital
- SEC CIK
- 0000934639
- Manager
- Lee Ainslie
- Style
- Hedge fund
NAMS holding history
NewAmsterdam Pharma Co N.V.
Every 13F filing in which Maverick Capital reported holding NAMS, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
NAMS overviewAll 13F holders of NAMSFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2026 | 3,267,802 | $110.75M | 1.00% | +1,081,400+49.5% | Added |
| Q1 2026 | 2,186,402 | $69.99M | 0.81% | +292,176+15.4% | Added |
| Q4 2025 | 1,894,226 | $66.45M | 0.71% | +389,479+25.9% | Added |
| Q3 2025 | 1,504,747 | $42.8M | 0.57% | −27,127−1.8% | Reduced |
| Q2 2025 | 1,531,874 | $27.74M | 0.43% | +982,405+178.8% | Added |
| Q1 2025 | 549,469 | $11.25M | 0.20% | +199,464+57.0% | Added |
| Q4 2024 | 350,005 | $9M | 0.16% | +350,005 | New |